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DNA methylation 5-methylcytosine (5mC) predicts a compacting chromatin inaccessible
to transcription. The discovery of 5-hydroxymethylcytosine (5hmC), which is derived
from 5mC, adds a new dimension to the mechanism and role of DNA methylation in
epigenetics. Genomic evidence indicates that the 5hmC is located in the alternate regions
to 5mC. However, the nature of 5hmC, as compared with classical 5mC remains unclear.
Observing the mouse brain through embryonic development to the adult, first, we found
that 5hmC is not merely an intermediate metabolite of demethylation, but is long lasting,
chromatically distinct, and dynamically changing during neurodevelopment. Second, we
found that 5hmC distinctly differs from 5mC in its chromatin affiliation during neural stem
cell (NSC) development. Thirdly, we found both 5mC and 5hmC to be uniquely polarized
and dynamic through the NSC development. 5mCwas found to progressively polarize with
MBD1 and MeCP2, and recruits H3K9me3 and H3K27me3; while 5hmC progressively
co-localizes with MBD3 and recruits H3K4me2. Critical differential binding of 5mC with
MBD1, and 5hmC with MBD3 was validated by Resonance Energy Transfer technique
FLIM-FRET. This transition and polarization coincides with neuroprogenitor differentiation.
Finally, at the time of synaptogenesis, 5mC gradually accumulates in the heterochromatin
while 5hmC accumulates in the euchromatin, which is consistent with the co-localization
of 5hmC with PolII, which mediates RNA transcription. Our data indicate that 5mC and
5hmC are diverse in their functional interactions with chromatin. This diversity is likely to
contribute to the versatile epigenetic control of transcription mediating brain development
and functional maintenance of adult brain.
Keywords: epigenetics, 5-methylcytosine, 5-hydroxymethylcytosine, chromatin remodeling, histone code, confocal
microscopy, FLIM-FRET
INTRODUCTION
Since its discovery as the second form of DNAmethylation in ver-
tebrate tissue, 5-hydroxymethylcytosine (5hmC), which is most
abundant in the brain (Globisch et al., 2010), has been in the eye
of the epigenetic storm (Kriaucionis and Heintz, 2009; Tahiliani
et al., 2009; Guo et al., 2011; Ito et al., 2011). The discovery
of 5hmC opens a new route for established DNA methylation
to regulate gene expression. 5hmC, the oxidized form of 5mC
by the ten-eleven translocation 1, 2, or 3 (TET1,2,3), can be
demethylated, also by TET1,2,3, into 5-formylcytosine (5fC) and
further into 5-carboxylcytosine (5caC) (Wolffe et al., 1999; Wu
and Zhang, 2010; Bhutani et al., 2011). The TET enzyme and the
generation of 5hmC have been found to be involved in program-
ming and maintenance of the pluripotency of embryonic stem
(ES) cells (Ito et al., 2010) and totipotency of zygotes (Wossidlo
et al., 2011). Current research on 5hmC has primarily focused
on its biochemical characterization in vitro and, primarily on its
involvement in stem cells and germ lines. Roles of 5hmC beyond
totipotent cells have been highly anticipated. We first showed
that 5mC and 5hmC form a collaborative program leading the
neuronal differentiation during neural tube development (Zhou
et al., 2011; Zhou, 2012), that prevention of the program retards
the differentiation, and the program also occurs in developing as
well as adult neuronogenesis in the hippocampus (Chen et al.,
2013). Recent finding on genomic reorganization of DNAmethy-
lation point to a potential role in synaptogenesis (Lister et al.,
2013). To date, the individual function of the 5mC and 5hmC
is not clear and is paramount to the understanding of transcrip-
tion in general, and brain development and function in many
ways. While 5mC’s association with suppression of transcription
is well accepted, the role of 5hmC is unclear (Bhutani et al.,
2011). Recent genomic distribution analyses showed that 5hmC
and 5mC are distributed in proximity to different categories of
histone codes in the embryonic stem (ES) cells (Pastor et al., 2011;
Stroud et al., 2011; Williams et al., 2011; Xu et al., 2011), which
implicates the potential deviation of their action in ES cells.
Here, we attempt to elucidate the epigenetic role of 5hmC
during brain development throughout adult brain. First, we
examined 5hmC along with 5mC from early gestation (E8) and
throughout the life span of the brain of mice. Second, DNA
methylation binding domain (MBD) proteins such as MBD1 and
3 were studied here in conjunction with 5mC and 5hmC. Third,
we characterized the relationship with histone codes and chro-
matin. Since DNA methylation is tissue specific, the dynamic
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changes between 5hmC and 5mC and their associated chro-
matin markers including select histone codes and MBDs, were
evaluated immunocytochemically. Since the physical proxim-
ity of the methylcytosine to MBD is difficult to ascertain by
immunocytochemistry, the differential binding of 5mC/5hmC
to their MBD partner is further confirmed with high-fidelity
Fluorescence Lifetime Imaging based Forster Resonance Energy
Transfer (FLIM-FRET).
We report here how 5mC and 5hmC achieve functional diver-
sity through differential temporal appearance, chromatin distri-
bution, and binding partner selection in the brain.
MATERIALS AND METHODS
ANIMALS
All mice were used in accordance withNational Institute of Health
and Indiana University Animal Care and Use (IACUC) guide-
lines and internationally recognized guidelines. The protocol was
approved by the Laboratory Animal Resource Center (LARC) ani-
mal ethics committee of Indiana University (protocol ID: 10428).
All efforts were made to assure minimal pain and discomfort.
C57BL/6 (B6) mice (average 20 grams, 12–14 week old, Harlan,
Inc., Indianapolis, IN) were used in this study. Mice were accli-
mated for at least 1 week before mating. For embryo study, two
females were bred with one male for a 2-h period (10:00am–
12:00noon). The presence of a vaginal plug at the end of the 2-h
mating was considered as indicative of conceptus and that hour
was designated as embryonic day (E) 0. On E10 and 17 (each
n = 8–10), four of the dams were deep anaesthetized with CO2
and embryos were surgically removed from the embryonic sack
and fixed in 20ml of 4% ice-cold paraformaldehyde (PFA). Dams
were then euthanized with cervical dislocation. The rest of the
dams gave birth, which was designated postnatal day (P) 0. On
P7, P21, and P45 (n = 5–10 each), mice were anaesthetized with
CO2, and then perfused transcardially with 0.9% saline (100ml)
and 4% formaldehyde in phosphate buffer (0.2 M, pH 7.4). In
addition, a group of 3 about 1 year old mice were also used for
analysis. The brains were then removed, and post-fixed for at least
24 h at 4◦C.
IMMUNOHISTOCHEMISTRY
The embryos and postnatal brain of various ages (E10, E17, P7,
P21, P45, and 1 year old) were embedded in gelatin block and
fixed with 4% PFA for 48 h and sectioned in 40-μm-thick coro-
nal sections on a free-floating vibratome (Leica Microsystems;
Buffalo Grove, IL) for immunocytochemical procedures. The sec-
tions were then cleared of endogenous peroxidases using 10%
H2O2 in phosphate buffered saline (PBS) for 10min, and per-
meabilized with 1% TritonX-100 in PBS for 30min. DNA was
denatured with 2N HCL for 30min, and then neutralized in Tris-
HCl (PH 7.4) for 10min. Sections were blocked using a goat
kit containing 1.5% normal goat serum, 0.1% Triton X-100 in
PBS for 1 h, then incubated with primary antibodies. Antibodies
used were against DNA methylation marks 5mC (1:2000, mouse
monoclonal; Eurogenetec, Fremont, CA), 5hmC (1:3000, rabbit
monoclonal; Active Motif, Carlsbad, CA; The specificity of the
crucial anti-5hmC antibody is characterized by pre-absorption
of anti-5hmC antibody with 5hmC; See Figure A1); DNA
methylation binding proteins MeCP2 (methyl CpG binding pro-
tein 2, 1:1000, rabbit monoclonal; Cell Signaling, Danvers, MA),
MBD1(methyl CpG binding protein 1, 1:500, Millipore, Billerica,
MA), MBD3 (methyl CpG binding protein 3, 1:1000, Santa
Cruz Biotechnology, Dallas, Texas); DNA methylation enzyme
Tet1(ten-eleven translocation 1, a 5hmC hydroxylation enzyme;
1:500, rabbit polyclonal; Millipore, Billerica, MA); 5mC metabo-
lites 5-carboxylcytosine (5caC, 1:1000, Active Motif, Carlsbad,
CA) and 5-formylcytosine (5fC, 1:1000, Active Motif, Carlsbad,
CA); histone marks, trimethyl-H3K4 (H3K4me3, rabbit mon-
oclonal, 1:1000, Millipore, Billerica, MA), trimethyl-H3K9
(H3K9me3, 1:500, Millipore, Billerica, MA), trimethyl-H3K27
(H3K27me3, 1:500, Millipore, Billerica, MA); differentiation
markers MAP2 (goat, 1:400, Santa Cruz Biotechnology, Dallas,
Texas), anti-nestin (neuroepithelial marker, mouse, 1:500, BD
Biosciences, San Jose, CA), and anti-Crabp 1 (cellular retinoic
acid binding protein 1, received from Dr. Wei, University of
Missouri); and anti-serine-5 phosphorylated RNA polymerase
II (PolII) antibodies (Rabbit, 1:1000; Abcam, Cambridge, MA).
Primary antibody was diluted in PBS containing 0.1% Triton X-
100 and 1.5% normal goat-serum. The next day the sections were
washed three times in PBS, and then incubated with the corre-
sponding secondary antibodies conjugated with biotin (Jackson
ImmunoResearch, West Grove, PA) for single staining or fluores-
cent dyes (Invitrogen) and for double staining. For single staining,
the sections were further incubated in Streptavidin-AP (1:500,
Jackson ImmunoResearch, West Grove, PA) for 90min and visu-
alized with a brown-colored label, 0.05% 3′-3′-diaminobenzidine
(DAB), and 0.003% hydrogen peroxide. The sections were then
counterstained with methyl green, and dehydrated. For dou-
ble staining, a second set of primary antibodies were incubated
similarly to the first set followed by secondary antibodies with
fluorescent dye (Alexa 488, 546, or 633) for 1.5 h at room
temperature. Slices were covered with anti-fade mounting solu-
tion with 4′,6′-diamidino-2-phenylindole (DAPI) (Invitrogen).
Double-immunocytochemical staining was performed between
5mC and 5hmC, and the 5mC with MBD1, MeCP2, H3K9me3,
H3K4me2, or serine-5 phosphorylated PolII; and the 5hmC
with MBD3, H3K9me3, H3K4me2, or serine-5 phosphorylated
PolII.
IMAGE ACQUISITION
Confocal fluorescence images were obtained by an Olympus
FV1000-MPE Confocal Microscope (Olympus America Inc.,
Center Valley, PA) mounted on an Olympus IX81 inverted micro-
scope stand with a 60x water-immersed objective lens. Sequential
excitation at 488 nm and 559 nm was provided by argon and
diode lasers, respectively. Emissions were collected by spectral
detectors in channels one and two with user-specified min and
max wavelengths. A third channel, collecting fluorescence excited
at 405 nm was used for the detection of DAPI. Z-stack images
were collected over a thickness of 4.5μm with 0.3μm step inter-
vals. Laser intensities and gain values were adjusted to prevent
saturation and to reduce the background noise. The same set-
ting was used over the same pair of staining at different brain
locations and ages. After sequential excitation, green, and red flu-
orescence images of the same cell were saved and analyzed by
Frontiers in Genetics | Epigenomics and Epigenetics March 2014 | Volume 5 | Article 46 | 2
Chen et al. Diversity of DNA methylation
Olympus Fluoview FV10-ASW software (Olympus Corporation
2003–2008).
CO-LOCALIZATION ANALYSIS
For visualization of co-localization of confocal images, different
channels of images were overlaid at the same Z-plane. An overlay
of green and red would give rise to yellow hotspots where
the two molecules of interest were present in the same pixels.
Quantification of co-localization was performed with intensity
correlation coefficient-based method using an ImageJ plugin
JACoP (http://rsb.info.nih.gov/ij/plugins/track/jacop.html).
Methods were adapted from (Bolte and Cordelieres, 2006).
Pearson’s Coefficients (r) were collected for the area of interest in
nuclei. The value of r could range from 1 to −1, with 1 denoting
complete positive correlation, −1 for negative correlation, and 0
for no correlation. The value of M could vary from 0 to 1, with 0
corresponding to non-overlapping images and 1 reflecting 100%
co-localization. Each individual cell was outlined by ImageJ
selection tool and measured at the same threshold settings.
Only the nuclei with ±10% of the full diameter at section were
chosen for the analysis. For each pair of staining, ∼20 cells per
staining were measured, respectively, from 3 animals per age,
and presented as Mean ± SEM. Statistical analyses legitimately
evaluating colocalization adopted from McDonald and Dunn
(2013) were performed with ANOVA for groups or Student’s
T-test for pair comparisons.
FLUORESCENCE LIFETIME IMAGING BASED FORSTER RESONANCE
ENERGY TRANSFER (FLIM-FRET) ANALYSIS
The Immunocytochemistry procedure was done similar to the
one described above. In brief, formalin fixed brain tissue section
was used. The sections were washed in PBS 3 × 5min, then per-
meabilized using Triton-X 1% in PBS for 30min on a shaker.
The first antibody (5mC or 5hmC) was labeled with Alexafluor
488 conjugated secondary antibody at 1:500 dilution in nomal
goat serum, on a shaker for 90min, washed for 3 (3 × 5min;
3 × 15min; 4 × 30min) h. Tissue was then imaged and fluores-
cence lifetime was measured at the cortex and hypocampus area.
The same tissue section was washed for 30min on a shaker, and
then incubated with a pair of primary antibody (MBD1, MBD3,
or MeCP2) for 18 h, and labeled with Alexa fluor 546 conjugated
secondary antibody at 1:500 dilution for 90min, and mounted in
the imaging chamber for imaging. For each demethylation (5hmc,
5mc)/protein (MBD1, MBD3) interaction 50 cells are used from
∼8 cells/setion of hippocampal or cortical region of 4 P7 brains.
Total, 400 cells were used for FLIM-FRET analysis.
FLIM-FRET experiment was performed by measuring the
fluorescence lifetime of donor in the absence and the presence
of acceptor using Microtime 200 (Picoquant, GmbH, Berlin
Germany). Fluorescence lifetime is defined as the time in which
fluorescence intensity of a fluorophore is decreased to 1/e of its
initial intensity. The source of excitation is a picosecond pulsing
diode laser at 467 nm excitation wavelength for the donor (Alexa
fluor 488) and 530 nm for acceptor (Alexa fluor 546). The laser
repetition rate was 40mHz, and the laser power was ∼3mW.
The laser was focused on the sample using an apochromatic 60x
water immersion objective with1.2 NA. Off-focus fluorescence
was rejected with a 50μm pinhole for efficient collection of the
emission. Emitted fluorescence was collected using the same
objective and separated from excitation beam using dichroic
mirror. Band pass filter 480–520 nm for Alexa fluor 488, and
570–645 nm was used to ensure that the collected photons came
FIGURE 1 | The differential role of 5mC vs. 5hmC in the DNA
methylation program is inferred by their association with phenotypic
marks during the making of neural tube. At early neurulation (E10), a
sequential escalation of 5mC and 5hmC occurred, where 5mC appeared
first at neuroepithelial (A, NE) layer (arrowheads) to prepare the
differentiation, and faded as the NE cells differentiated and migrate away
from ventricle (A, arrows). At this time, the distribution of the DNA
methylation binding protein, MBD1, has exactly the same pattern as that of
5mC (B). Its function is depicted by the suppressive histone mark,
H3K27me3, which distributed (C) similar to that of 5mC and MBD1. The
demethylated metabolite 5fC also matched with 5mC. In contrast, the
5hmC appeared at differentiating neurons (E, arrowheads) and continued to
increase in differentiated neurons (E, arrows). This program also occurred at
ventro- (left) dorsal (right) gradation (A–H) where 5mC (A) preceded 5hmC
(E). The role of 5mC and 5hmC on neural tube cell differentiation is further
depicted by the differentiation phenotypic markers in a spatially precise
manner. The role of the 5mC is demonstrated by the appearance of the
Oct4 in the NE layer (F, arrowhead) and the loss of Oct4 in differentiated
neurons (F, arrow). The role of 5hmC is noted by the stage-wise neuronal
marker Crabp1 (G) and MAP2 (H) distributed in a spatially correlated
manner. V, ventral; D, dorsal. Scale bar: All = 100μm. Color scheme:
Immunoreactive DAB, brown; counterstaining, methyl green.
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from the donor fluorophore only. Fluorescence emission was
collected using two single photon avalanche photodiodes using
(SPAD, SPCM-AQR-14, Perkin-Elmer). Each photon was tagged
with a time stamp that identifies its arrival time in the detector
after the laser pulse, using time correlated single photon counting
(TCSPC) in the Time Tagged Time Resolved Single Photon Mode
(TTTR) and the FLIM image and the decay curve were obtained.
Details of instrumentation can be found in (Varghese et al., 2008;
Chen et al., 2012).
Fluorescence lifetime was obtained from the multiexponential
reconvolution fitting with the appropriate instrument response
function (IRF), following (Lakowicz, 2010; Chen et al., 2011):
I(t) =
n∑
i= 1
α1 exp
(
− t
ti
)
Time bin was applied to remove the background and threshold
was set for 500 photon per pixel. A minimum of 25 different
cells from 4 to 5 separate experiments were fitted for efficiency
calculations.
FRET efficiency (Vidi et al., 2008) was calculated by:
Efficiency = 1 − τa
τb
where:
τa = Fluorescence lifetime of donor with the absence of
acceptor
τa = Fluorescence lifetime of donor with the presence of
acceptor
Efficiency above 5% is considered as significant and vice versa
(Ruttinger et al., 2006).
Both the positive and negative controls were also performed
by FLIM- FRET to validate our findings. For positive control, we
demonstrated that the goat anti-mouse IgG Alexa 488 and don-
key anti-goat Alexa 546 IgG (depicting co-localization of the two
fluorophores, acceptor and donor,) were within the FRET dis-
tance denoting co-localization of the two marks. For negative
control, the primary mouse anti-5mC and the secondary anti-
mouse Alexa488 donor (blue channel) does not show any binding
proximity to the anti-rabbit Alexa 633 or anti-rabbit Alexa 546
(Acceptor red channel). (See Figure A2).
RESULTS
ONTOGENY OF DNA METHYLATION OF THE NERVOUS SYSTEM
At every point of neural differentiation in the neuroepithelial
cells throughout the neural tube and brain development, the
immunostained 5mC and 5hmC appeared or surged in tandem–
first the 5mC followed by 5hmC hours to days later. At embryonic
day (E) 8-E10, 5hmC and 5mC showed a distinct pattern in the
ventricle subpopulation of the neural tube. 5mC increased in a
spatiotemporal gradation, axially from the hindbrain to rostral
and caudal neural tube, and at each level from ventral to dorsal
aspects. This 5mC distribution gradient was found to correlate
spatiotemporally with the differentiation gradient in the neural
tube as reported previously (Zhou et al., 2011). In this report
we reveal that, it is the sharp increase of 5hmC, hours to days
after the increment of 5mC that marks the beginning of neuroep-
ithelial cell differentiation. Stages of differentiation were marked
FIGURE 2 | Progression of the 5mC and 5hmC commonly parallels with
the neuronal differentiation throughout the developing brain. Also, the
sequential escalation of 5mC precedes 5hmC at the stage of neural
differentiation in the cortex (A vs. D), striatum (B vs. E), and hippocampus (C
vs. F) (The degree of methylation is shown by the number of stars, where
lack of methylation is denoted by “o”). At the stage of early brain formation at
E17, the 5mC appeared in the neuroepithelial cells preempting for
differentiation (e.g., medial striatum and hippocampal neuroepithelium; B,C,
one red star area), and continue in the differentiating neurons in cortex (A),
lateral striatum (L-str, B), and CA regions (B, two red stars). The 5hmC arrives
in the cells initiated for differentiation, and the level of 5hmC parallel with the
stage of differentiation, e.g., subplate>cortical plate (D), lateral striatum
(L-str)> medial striatum (M-str) (E, white star), CA1>neuroepithelium (F,
white star). Counterstaining, methyl-green (green color). SVZ, subventricular
zone; CP, cortical plate; SP, subplate; NE, neuroepithelium; V, ventricle; DG,
dentate gyrus. Scale bar: A and D = 100μm; B,C,E,F = 100μm.
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by the sequential appearance of nestin, cRABP, and MAP2 stain-
ing (Figure 1). Immunocytochemical staining of 5hmC coincided
with that of Tet1/2 (Figure 1). Throughout all the regions of
the differentiating neural tube, the surge of 5hmC staining can
be related to a particular stage of differentiation. Both 5mC
and 5hmC clearly increased as differentiating neurons migrated
toward their targets.
The epigenetic pattern in the developing brain is very simi-
lar to that of the neural tube. At early postnatal stage (P7), 5mC
and 5hmC continue to evolve in the differentiating neurons in
the brain where neuroepithelial cells are undergoing differentia-
tion, while less 5mC-immunostaining (im) and no 5hmC-im are
noted in the undifferentiated neuroprogenitor cells in the fore-
brain. For example, an intense 5mC-im and moderate 5hmC-im
appeared in differentiated neurons in the lateral striatum, but a
low concentration of the 5mC-im and no 5hmC-im appeared in
the immature primordial cells inmedial striatum at P7 (Figure 2).
The timing and partnership of 5mC and 5hmC are well demon-
strated spatiotemporally in layer development of archicortex (e.g.,
hippocampus) (Chen et al., 2013) and the neocortex (e.g., frontal
cortex) (Figure 2). In more mature brain, e.g., at P45, higher
amounts of 5mC and 5hmC are distributed in all neurons and
glial cells, except the neural progenitor cells in the subventricular
zone and subgranular layer of the dentate gyrus where, 5mC-im
appeared in low level and 5hmC-im is mostly absent or extremely
low, recapitulating the prenatal early neurogenesis. Apparent
diverse density of the DNA methylation marks are evident in
different regions of the mature brain e.g., striatum vs. cortex,
and hippocampus (Figure 2) (As a note, the cellular methyla-
tion level in the cerebellum is not exceptionally higher than other
regions of the brain as previously indicated in vitro (Kriaucionis
and Heintz, 2009). High levels may be due to the biochemical
measurement in the high-density granule cells, or a discrepancy
between the in vitro and in vivo analysis.Within a region, different
intensities of 5mC-im and 5hmC-im were also found in different
populations of the neurons during the developmental stages. The
intensity of 5hmC in the brain cells varied to a greater degree than
that of 5mC. Both 5mC and 5hmC were maintained throughout
the young adult stage and in the 1-year-old. A reduction of 5hmC
and 5mC were found in both neurons (in gray matter) and glial
cells (in white matter) in ∼1-year-old brain.
CHROMATIN DYNAMICS
Initial observation of the surge of 5mC and 5hmC by con-
focal microscopy indicated a diffusely distributed pattern in
the nucleus (e.g., in ventral neural tube at E10, or in cortical
FIGURE 3 | Differential chromatin remodeling of the 5mC (green) and
5hmC (red) during neuroprogenitor cell differentiation. In the
developing cortex, both 5mC and 5hmC were diffusely distributed in
undifferentiated cells and many were overlapped at E17 (A–C, D:DAPI.
also see quantitation by Pearson’s Coefficient analysis in M), but polarized
into different compartments (E–G; arrows) as the neuron differentiated at
P7. The 5mC (E, arrowheads) became associated with DAPI-dense
heterochromatic region (H, arrowheads), while 5hmC in contrast with
DAPI-sparse eurchromatic region (B,F, arrowhead). The dissociation is
indicated by decrease of Pearson’s Coefficient between E17 and P 7
shown in chart m. ∗∗P < 0.005. Similar remodeling was found in the two
differentiating stage of cells within the P7 dentate gyrus (DG; I–L), where
undifferentiated or less differentiated (in inner layer, see N) and
differentiated cells (in outer layer) are layered (see N). The 5mC and
5hmC were both homogeneously distributed in younger granule cells
(I–L, arrows), but 5mC was translocated into heterchromatic DAPI-dense
compartments (I–L; crossed arrow), while 5hmC was located in
euchromatic DAPI-sparse compartment avoiding the heterchromatic
DAPI-dense granules (J,K, crossed arrow) in the mature granule cells.
Scale bar: (A–L) = 10μm. All staining is within nuclei.
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ventricular zone at E17). The degree of co-localization was indi-
cated by Pearson’s Coefficient and Manders’ Coefficient analysis
(see Methods). As the neuroprogenitors progressed to differen-
tiation, 5mC and 5hmC co-localization progressively decreased
and were finally found in a characteristic complementary mosaic
chromatin compartment in the differentiated state, which peaked
at early postnatal days (e.g., P7 in the differentiated corti-
cal, hippocampal CA neurons, and lateral striatum). Thus, the
5mC and 5hmC within differentiated neuronal nuclei are dis-
tinctively distributed in different chromatin compartments, and
differentially associated with varying chromatin states. The 5mC-
im distributed in 4′,6′-diamidino-2-phenylindole (DAPI)-dense
aggregates of heterochromatin regions (∼0.5–1.5μm) is com-
pletely void of 5hmC-im. The 5hmC-im is solely distributed in
fine, DAPI-sparse euchromatic regions (<0.3μm), which also
contain small amount of 5mC (Figure 3). Chromatin remodel-
ing is revealed by the co-localization analysis over a period of
time. The mosaic distribution of the 5hmC and 5mC is also
demonstrated by their association with DNAmethylation binding
proteins and histone codes associated with gene transcription
states shown below.
DIFFERENTIAL BINDING PARTNERS
5mC and 5hmC are differentially associated with methyl CpG
binding domain (MBD) protein in neurons throughout the
brain (e.g., cortices, hippocampus, and cerebellum). By confo-
cal microscopy, double staining revealed a distinct partnership
between MBDs and the 5mC and 5hmC. MeCP2 appeared in the
neural tube where neurons formed as early as the mouse embryo
day 10 (E10) following the appearance of 5mC by approximately
a day. The 5mC co-localized with the MeCP2 with remarkably
high-fidelity (Figure 4). The co-localization was found in the
large DAPI-dense aggregates as well as in the fine DAPI-sparse
chromatin particles in the differentiated neurons. In contrast,
the 5hmC, which is devoid of DAPI-dense aggregates, does not
overlap with aggregated (heterochromatic) MeCP2 in either com-
partment of the chromatin (Figure 4). Co-localization of 5mC
and its binding partners MeCP2 and MBD1 evolved as the brain
FIGURE 4 | The transitional association of MeCP2 from 5mC to 5hmC
during neuronal maturation. The association of MeCP2 with 5mC is
consolidated as neurons mature shown in the cortex. Nuclear distribution of
methyl-binding protein 2 (MeCP2) is homogeneous and mildly associated
with 5mC (A–D) at E17 but greatly increased at P7 in cortex (E–H). Pearson’s
Coefficient (r) for co-localization was shown in the chart (Q). In contrast, the
homogeneously (euchromatic) distributed MeCP2 colocalized with 5hmC at
E17 (I–L, arrowhead), but the aggregated (heterochromatic) MeCP2
dissociated with 5hmC (colocalized instead with 5mC as shown in E–H) in
more mature neurons at P7 (M–P, arrowhead). Pearson’s coefficient for
co-localization was shown in chart (R). Scale bar: All = 10μm. It is shown that
MeCP2 (D,N; arrowheads) are mostly distributed at DAPI-dense region with
heterchromatin (D,H; arrowheads) where 5hmC is usually absent (I,M;
arrowheads). Scale bar: all = 10μm. ∗p < 0.05.
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developed, with co-localization of 5mC and MeCP2 occurring
prior to that of 5mC andMBD1. The 5mC andMBD1 which were
partially colocalized and homogeneously distributed in DAPI-
sparse regions in early development (e.g., at E17), became highly
colocalized and translocated to mostly heterochromatic aggre-
gates in the cortex (Figure 5) and other brain regions of similar
maturation stage. In contrast, the 5hmC-im is highly co-localized
with MBD3 throughout specific brain regions, e.g., in cortex
(Figure 5). The 5mC and MBD3 localization in contrast has been
low (not shown).
To better enumerate and validate the binding partners, DNA
methylation-MBD interaction in real-time, Fluorescence Lifetime
Imaging based Forster Resonance Energy Transfer (FLIM–FRET)
approach was utilized for precise evaluation of the interactions.
We demonstrated that there was low interaction between 5hmC
and MBD1 in either hippocampus (FRET efficiency 2.98%) or
FIGURE 5 | Differential DNA methylation binding protein partners
and their co-translocation during chromatin remodeling over the
stage of neuronal maturation. Two color-fluorescent confocal
microscopy shows that the 5mC (red) predominantly co-localized (A,
red) with MBD1 (B, green) initially in the homogeneous small
punctate form at nuclei of young E17 neurons at layer IV of cortex
(Cx) (C), and increasing their co-localization (P) and strikingly
co-located in the heterochromatin aggregates when became more
differentiated by P7 (D–F, arrows). The colocalization of 5hmC (G,
green) with MBD3 (H, red) were seen at E17 (not shown) and P7
(G–I, Pearson’s Coefficient is shown in Q) in the cortex and in the
dentate gyrus (R). The 5hmC co-locates with MBD3 to homogeneous
euchromatic region (DAPI sparse, now show) from young neurons at
inner layer of dentate gyrus (DGi, J–L) to older outer layer dentate
gyrus (DGo, M–O). Scale bar: All = 10um. The Pearson’s Coefficient
analyses of colocalization are shown on (P–R). ∗p < 0.05.
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cortex (FRET efficiency 1.11%) (Figure 6A). In contrast, strong
interaction between 5mC and MBD1 (FRET efficiency 8.57–
9.65%) (Figure 6B) and between 5hmC and MBD3 (FRET effi-
ciency 7.68–8.40%) in both hippocampus and cortex (Figure 6C)
were noted.
DIFFERENTIAL ASSOCIATION WITH SPECIFIC CODE OF HISTONE AND
TRANSCRIPTION SITE
The double-staining of DNAmethylation with histone codes indi-
cated that 5mC favorably co-localizes with H3K9me3 and with
H3K27me3, which are mostly located in the DAPI-dense aggre-
gates (Figure 7). On the contrary, 5hmC does not co-localize with
H3K9me3 or H3K27me3. Instead, it co-localizes with H3K4me2
in the DAPI-sparse regions while a lack of co-localization between
5mC with H3K4me2 (Figure 7) is noted. The divergent 5mC
and 5hmC co-localization with histone codes is independent
of the development stage (e.g., E17, P7, P28) and is observed
throughout the brain (the cortices, hippocampus, brainstem, and
cerebellum).
The differential role of 5mC and 5hmC is summarized
by its association with the PolII transcription enzyme for
transcription initiation (Serine-5 phosphorylated PolII) (Cho
et al., 2001; Cheng and Sharp, 2003). A strong co-localization
of 5hmC with PolII was shown during neuronal differen-
tiation throughout the emerging (E17) stage and slightly
decreased in more matured (P7) neurons as demonstrated in
the cortex (Figure 8). The co-localization between 5mC and
PolII was transient and dissociated as neuronal differentia-
tion progressed at P7 as indicated by the Pearson’s coefficient
(Figure 8I).
STABLE EXISTENCE OF DEMETHYLATION INTERMEDIATES 5hmC, 5fC,
AND 5caC
Although a slight reduction in the subpopulation of cells was
observed, the 5mC and 5hmC remain throughout, in ∼1 year-old
brain (e.g., thalamus, basal ganglia) compared to that of young
adult. 5hmC’s appearance in the prenatal stage shows that it is a
prominent feature in neural cells, and persists throughout the life
span in the brain as observed in our early time points of E8 and
E10, to P7, P21, P45, and 1 year-old (Figure 9). Apparently, 5hmC
is not a temporary intermediate as noted from samples obtained
from different ages of the brain. We next observed that the
demethylation forms, 5fC and 5caC, which exist in smaller con-
centration compared to that of 5mC and 5hmC, appear during
FIGURE 6 | (A) There is no significant FRET between MBD1 and 5hmC in
the hippocampus (a) MBD1 (b) MBD1/5hmC, and in cortex (c) MBD1 (d)
MBD1/5hmC. There is no significant change (P > 0.05) (FRET efficiency
<3%) of the lifetime of donor in the cortex and hippocampus. Average
lifetime (e) of MBD1 was 1.53 ns, and MBD1/5hmC was 1.51 ns in cortex,
and MBD1 was 1.5 ns and MBD1/5hmC was 1.47 ns in the hippocampus.
(B) There is a significant FRET between 5mC and MBD1 in hippocampus:
(a) 5mC (b) MBD1/5mC, and in cortex (c) 5mC (d) 5mC/MBD1. There was
a significant decrease (P < 0.05) (FRET efficiency >5%) in the lifetime of
donor in the cortex and hippocampus. Average lifetime (e) of 5mC was
2.45 ns and 5mC/MBD1 was 2.17 ns in cortex, 5mC was 2.42 ns and
5mC/MBD1 was 2.22 ns in the hippocampus. (C) There is a physical
interaction between 5hmC and MBD3 in hippocampus (a, 5hmC; b,
MBD3/5hmC) and in cortex (c, 5hmC; d, 5hmC/MBD3). There is a
significant decrease (P < 0.05) (FRET efficiency >5%) of lifetime donor in
cortex and hippocampus. Average lifetime (e) of 5hmC was 2.45 ns, and
5hmC/MBD3 was 2.17 ns in cortex; and 5hmC was 2.42 ns, and
5mC/MBD3 was 2.22 ns in the hippocampus.
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FIGURE 7 | Differential colocalization of 5mC and 5hmC with histone
marks in nuclei of differentiated neurons in P7 cortex indicated by two
color-fluorescence confocal microscopy. The 5mC (A,D, red) is closely
colocalized with suppressive histone marks H3K9me3 (B, green) (merged in
C), and H3K27me3 (E, green) (merged in F). In contrast, the 5hmC (G, red)
is highly co-localized with the activating histone mark, H3K4Me2 (H, green)
as demonstrated in the merged image (I). Pearson’s coefficient is shown in
chart J. Data presented as Mean ± SEM.
early development (E10, E17) and exist in the nervous system
from the prenatal stage throughout adulthood (e.g., P21, P45)
(Figure 9). Thus, it is evident that the demethylation intermediate
and the demethylated cytosine variants are lastingmarks onDNA.
DISCUSSION
5mC AND 5hmC TRANSITION DURING DEVELOPMENT
5mC and 5hmC co-distribute as early as in the zygote stage, where
most of the DNA methylation is inherited. Global demethyla-
tion eliminated most of the DNA methylation in the early zygotic
development during implantation (Kafri et al., 1993; Morgan
et al., 2005; Inoue et al., 2011; Iqbal et al., 2011; Salvaing et al.,
2012). We found that during neurulation there is a sharp esca-
lation of DNA methylation. The escalation is not random but
rather progressed in a pattern closely associated with the state
of differentiation of the neuroprogenitor cells. Both 5mC and
5hmC progressed in the newly differentiated neuroepithelial cells
as observed from the spatiotemporal patterns in the neural tube
and developing brain. However, there are two major differences
between the two DNA methylation marks. First, the temporal
surge of 5mC and 5hmC is punctual (at very specific stage of
neural differentiation) and step-wise (always escalation of 5mC
first and followed with 5hmC) throughout developing pre- and
postnatal brain (where neural differentiation occurs). The lat-
ter is not surprising since it is in agreement with the sharp rise
of the TET enzyme, which oxidizes 5mC into 5hmC (Figure 1).
However, very interestingly, it is the timing of the surge of 5hmC,
but not 5mC, that marks the initiation of neural progenitor cell
differentiation. Our experiments show that the escalation of 5mC
coincides with the shutdown of proliferation just prior to neu-
ral stem cell differentiation; and that the surge of 5hmC, which
is involved in transcription, coincides with neural differentiation.
The transition from 5mC to 5hmC upon initiation of progeni-
tor cell differentiation and determination of cell fate is ubiquitous
throughout the brain regions observed and depending on the
stage of neural stem cells instead of overall age of the brain. This
pattern is carried into the adult neural stem cells, where 5mC and
5hmC sequentially escalated in newly stem post-mitotic mature
neurons, while little-to-low 5hmC is observed in undifferentiated
adult progenitor cells near the ventricle and in the hippocampal
sub-granular layer (Chen et al., 2013).
5hmC IS NOT A TRANSIENT INTERMEDIATE
Is 5hmC merely an intermediate state of demethylation, serv-
ing no biological function? Recently, instead of being transient
and unstable, 5hmC was detected as a relatively stable epige-
netic marker in ES or zygotic cells (Inoue and Zhang, 2011;
Iqbal et al., 2011). The following evidence lead us to believe
that 5hmC is not a transient intermediate of demethylation,
although it is not without turnover, as we previously indi-
cated in the ontogeny of DNA methylation (Zhou et al., 2011;
Zhou, 2012). Our observations that 5mC and 5hmC co-distribute
throughout neurulation and brain development, and that 5hmC
exists and persists throughout the life span of neurons strongly
argues against the notion that 5hmC is merely an interme-
diate product. Further, we found the demethylation products
5fC and 5caC, which are also recently being considered for
potential functionality (Burgess, 2012; Kellinger et al., 2012),
are stably expressed in the developing neurons and through-
out the mature brain. Taken together, this evidence support
our claim that that 5hmC is a long-standing and dynamic
component.
5hmC IS A LEAGUE OF ITS OWN
Is 5hmC a genuinely new breed of DNAmethylation? Apparently,
5hmC and 5mC can be discriminated via their binding partners.
Our evidence thus far suggests that at least they are read by dis-
tinctly different binding proteins—5mC preferentially binds to
MeCP2 and MBD1, while 5hmC preferentially binds to MBD3.
Recent reports indicate a mix view on the association of 5hmC
vs. 5mC to MBD3 (Yildirim et al., 2011; Hashimoto et al., 2012;
Spruijt et al., 2013). All these studies were conducted in vitro and
mostly in ES cells. Given the dynamic nature of DNA methyla-
tion, the evolution of the respective binding partner is also likely
dynamic, potentially resulting in differences between in vitro and
in vivo interactions. Our observations, obtained throughout brain
development demonstrated that there is a dynamic transition of
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FIGURE 8 | Differential co-localization of Pol II (transcription elongation
enzyme) with 5hmC over 5mC in the cortex as demonstrated in
confocal microscopy. At stage of early differentiating (E17), both 5mC
(A–D) and to a greater extend 5hmC (E–H) are associated the PolII. As
neurons mature (P7), PolII dissociates with 5mC (I–L,Q, arrows), while
specifically associates with 5hmC (M–Q). The 5hmC (red) and PolII
(green) sites are all in the euchromatic regions exclusive from DAPI
stained heterochromatic region (blue, Arrow). Pearson’s analysis of
co-localization of DNA methylation marks and Pol II indicates that the
initial co-localization between 5mC and PolII were notedly was
diminished at the later stage (Q). This observation summarizes the
differential role of 5mC and 5hmC on transcription. ∗p < 0.05.
this differential binding coincident with neuronal differentiation
through the neural developmental stage (Figure 5). The bona
fide differential binding activities of 5mC with MBD1 and 5hmC
with MBD3 partners are demonstrated here by the FLIM-FRET
analysis for the first time (Figure 6). This observation affirms
the previous finding which points to the fact that in differential
genomic distribution that 5mC is preferentially localized in the
promoter regions of the gene, while 5hmC and MBD3 is prefer-
entially distributed in the downstream transcription starting sites
(TSS) in the gene body regions (Stroud et al., 2011; Wu et al.,
2011; Yildirim et al., 2011).
Functionally, the genes associated with 5hmC in the gene bod-
ies are actively transcribed in the mouse embryonic stem cells
and mouse cerebellum (Guo et al., 2011; Pastor et al., 2011;
Wu et al., 2011). The functional diversity of the two forms of
DNA methylation is further suggested in the current study by
their cellular affiliation first with correspondent histone codes—
5mCwith the suppressive H3K9me3 and withH3K27me3,mostly
in the heterochromatin regions; and 5hmC with H3K4me2 in
the euchromatin regions (Figure 7). This methylation transition
and histone code affiliation is also demonstrated at the genomic
level. 5hmC is enriched in the TSS in the gene body close to
regions of H3K4me2, but not near H3K9me3 regions. Further,
5hmCs are also enriched in regions associated with activating
the histone codes H3K4me1 and H3K27ac (Stroud et al., 2011).
In genes, 5hmC transitions from silent to activated, and was
found to affiliate with the activating H3K4me3 and suppres-
sive H3K27me3 in ES cells (Pastor et al., 2011; Williams et al.,
2011). Perhaps the strongest evidence that we have observed
is the co-localization of 5hmC with PolII in the euchromatin
regions throughout neuronal differentiation, and the transient
and complete dissociation of 5mC and PolII throughout chro-
matin in nucleus (Figure 8). Together, these observations indicate
that the conversion of 5mC to 5hmC is a dynamic process that
may serve as a means for transcriptional transition to regu-
late ES cells in previous studies (see introduction) and those of
the developing nervous system (Zhou et al., 2011; Zhou, 2012;
Chen et al., 2013). On the other hand, after 5hmC has set-
tled in mature neurons, significantly long-term high levels of
5hmC, as well as 5fC and 5caC, were observed through adult-
hood. This indicates that 5hmC is not a transient intermedi-
ate toward demethylation, rather it is highly associated with
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FIGURE 9 | DNA methylation intermediates were observed to be
persistent throughout the life in the brain. A few examples are shown
here. The 5hmC persists in the cortex (A) and hippocampus (B) in 1
year-old brain. The demethylated cytosine marks also prevailed. The 5fC is
shown in the hippocampus at P21 (C), and 5caC (D) in cerebellum at P45.
euchromatin and likely maintains the activity of genes for cell
specificity.
CHROMATIN REMODELING
The significance of the escalation of 5mC and 5hmC during
the course of neuroepithelial cell differentiation has to do with
chromatin remodeling and DNA packaging. We found that the
selective DNA methylation and histone marks are progressively
distributed differentially to correspond with the DAPI-dense vs.
-sparse chromatin compartments. In the developing brain, at
perinatal stage (E15-P7), 5mC relocates from DAPI sparse to the
DAPI-dense heterochromatin, while 5hmC affiliates with DAPI-
sparse euchromatin. The 5mC and 5hmC associated chromatin
remodeling peaking at P7 coincides with synaptogenesis. Another
event of DNA methylation reconfiguration—where CpG methy-
lation (mCG) is switching to non-CpG methylation (mCH) also
coincides with synaptogenesis (Lister et al., 2013). These two
events highlight the dynamics of DNA methylation during brain
development.
The above distinct differential affiliations provide a major clue
suggesting a departure of 5hmC from 5mC and a transition
toward transcriptional activation. It infers that the transition
from 5mC to 5hmC is pertinent to chromatin remodeling and to
DNA packaging in the different compartments for the silenced
vs. activated gene cohorts for timely functional or develop-
mental progression during neural fate determination or tissue
specification. The differential association of 5mC with suppres-
sive histone codes, and 5hmC with activation histone code,
further support chromatin remodeling to organize the tran-
scription transition. An epigenomic-gene expression analysis in
the hippocampus and cerebellum (Szulwach et al., 2011) sup-
ports this view. Meehan et al. (Nestor et al., 2012) recently
further demonstrated that 5hmC is associated with transcribed
genes.
CONCLUSIONS
We demonstrated that 5mC dramatically increased in the neu-
roprogenitor cells during priming for differentiation, and pref-
erentially binds to MBD1 (as indicated by FLIM-FRET), and
colocalizes with MeCP2, histone H3K9me3 and H3K27me3, and
is finally packed into heterochromatin during and after neural
differentiation. 5mC is likely to organize a more selective tran-
scription during differentiation. In contrast, 5hmC surged at
the initiation of differentiation of neuroepithelial cells, prefer-
entially bound to MBD3, colocalized with the euchromatin his-
tone H3K4me2, and gradually translocated to the euchromatin,
demonstrating a transition to transcription that is needed for dif-
ferentiation. Thus, 5mC and 5hmC, which divided into different
chromatin and differentially associated with distinct functional
partners through development and remained in adulthood, likely
represent functionally unique DNA methylations in the epige-
netic landscape. This added complexity in the epigenome may
increase the efficiency with which the complex journey of devel-
opment is accomplished, and may improve the responsiveness of
the system to the environmental inputs (Zhou, 2012; Chen et al.,
2013; Resendiz et al., 2013).
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APPENDIX
FIGURE A1 | The specificity of the anti-5hmC antibody. The specificity of
the crucial anti-5hmC antibody against 5hmC was characterized by
pre-absorption of anti-5hmC antibody (1:1000, rabbit polyclonal IgG, Active
Motif) with 5hmC synthesized DNA (Methylated DNA Standard Kit, #55008,
Active Motif, 50 ng/μl, at a working dilution of 1:20 molar ratio) overnight at
4◦C. Before absorption, the anti-5hmC immunostaining in the cortex shows
distinct 5hmC staining pattern (A) as described in the result, while the
staining pattern was abolished or drastically reduced after
5hmC-preabsorption (B).
FIGURE A2 | Positive and negative control study by FLIM-FRET.
(A) Negative control: There is no interaction between mouse IgG
Alexa488 and anti Rabbit IgG Alexa546. (a) Average lifetime anti-5mC
mouse IgG Alexa488 was 2.128 ns. (b) Average lifetime of anti-5mC
mouse IgG Alexa488 and mouse anti rabbit-ant IgG Alexa546 was
2.120 ns. There is no significant change (FRET efficiency >0.05 and at
P > 0.05) between mean lifetime of donor and acceptor in
hippocampus. (B) Positive controls: There is interaction between
goat/anti-mouse IgG Alexa488 and anti-goat IgG. (a) Average lifetime
of goat-anti mouse IgG Alexa488 was 3.8 ns, while (b) the average
lifetime of goat anti-mouse IgG Alexa488 and anti-goat IgG Alexa546
was 2.6 ns. There is significant change (FRET efficiency >0.05 and at
P < 0.05) between mean lifetime of lifetime donor and acceptor in
the hippocampus.
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